![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.21, Iss.3, 2003-01, pp. : 149-157
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
UK NICE methodological guidelines not hitting their mark
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 399, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The UK National Health Service is too strapped for cash to adhere to guidelines
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 349, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The UK NICE is recommending rituximab for use on the NHS in England and Wales
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 581, 2009-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)